Jose R Arribas

Jose R Arribas

UNVERIFIED PROFILE

Are you Jose R Arribas?   Register this Author

Register author
Jose R Arribas

Jose R Arribas

Publications by authors named "Jose R Arribas"

Are you Jose R Arribas?   Register this Author

100Publications

1868Reads

-Profile Views

New filovirus disease classification and nomenclature.

Nat Rev Microbiol 2019 May;17(5):261-263

World Health Organization Regional Office for Africa, Brazzaville, Democratic Republic of the Congo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41579-019-0187-4DOI Listing
May 2019

Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.

J Infect Dis 2018 Nov;218(suppl_5):S574-S581

Department of Microbiology, Instituto de Investigación Hospital 12 de Octubre, Hospital Universitario 12 de Octubre, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiy302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249609PMC
November 2018

Autochthonous Crimean-Congo haemorrhagic fever in Spain: So much to learn.

Enferm Infecc Microbiol Clin 2018 03 24;36(3):202. Epub 2017 Jun 24.

Hospital Universitario La Paz-Carlos III, Infectious Diseases Unit, Internal Medicine Department, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eimc.2017.05.004DOI Listing
March 2018

A safety evaluation of raltegravir for the treatment of HIV.

Expert Opin Drug Saf 2018 Feb 5;17(2):217-223. Epub 2017 Dec 5.

a HIV Unit, Internal Medicine Service , Hospital Universitario La Paz-IdiPAZ , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2018.1411903DOI Listing
February 2018

New Strategies of ARV: the Road to Simplification.

Curr HIV/AIDS Rep 2018 02;15(1):11-19

HIV Unit, Internal Medicine Service, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11904-018-0371-6DOI Listing
February 2018

Persistence and infectivity of Zika virus in semen after returning from endemic areas: Report of 5 cases.

J Clin Virol 2017 11 13;96:110-115. Epub 2017 Oct 13.

Infectious Diseases Unit, Department of Internal Medicine, Hospital Universitario La Paz-H, Carlos III, IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2017.10.006DOI Listing
November 2017

Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients.

J Acquir Immune Defic Syndr 2017 09;76(1):102-109

*HIV Unit, Internal Medicine Service, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain; †Microbiology Service, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain; ‡Universidad de Alcalá de Henares, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; and §Instituto de Investigaciones Biomédicas CSIC/UAM, IdiPAZ, Biomarkers and New Therapies and CIBER de enfermedades raras (CIBERER), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001391DOI Listing
September 2017

Autochthonous Crimean-Congo Hemorrhagic Fever in Spain.

N Engl J Med 2017 07;377(2):154-161

From the Arbovirus and Imported Viral Diseases Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III (A.N., M.P.S.-S., E.R.A., F.L.), Red de Investigación Colaborativa en Enfermedades Tropicales (A.N., M.P.S.-S., E.R.A., F.L.), High Level Isolation Unit (F.C.-P., M.M.-R., A.M.-Q., E.T., J.C.F., J. Manzanares, O.R.-F., V.M.C., J.R.A.) and Departments of Preventive Medicine (N.G.-A.) and Occupational Health (M.V.F.-D.), La Paz University Hospital, Intensive Care Unit (E.P.-H., A.M.G., L.L.P., D.D.-D., M.A.L.-G.) and Departments of Internal Medicine (B.S.-A.), Emergency (J.L.F.), and Occupational Health (P.D.-J.), Infanta Leonor University Hospital, Epidemiology Area of the Autonomous Community of Madrid (J.A.-M., M.O.G., E.R.-B., L.G.-C.), Intensive Care Unit (E.B.L., E.K.-D.) and Departments of Pathology (J. Menárguez, J. Milla) and Clinical Microbiology and Infectious Diseases (A.F.-C.), Gregorio Marañón University General Hospital, and Instituto de Investigación Sanitaria Gregorio Marañón, Complutense University (J. Menárguez, J. Milla, A.F.-C.) - all in Madrid; and the World Health Organization Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (P.E., J.S.-C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615162DOI Listing
July 2017

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.

J Acquir Immune Defic Syndr 2017 06;75(2):211-218

*Infectious Diseases Unit, Internal Medicine Service, Hospital Universitario La Paz, Madrid, ES; †AIDS Research Consortium of Atlanta, Atlanta, GA; ‡Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; §Internal Medicine, General Hospital Graz-West, Graz, AT; ‖Tarrant County Infectious Disease Associates, Fort Worth, TX; ¶Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC; #Orlando Immunology Center, Orlando, FL; **Claude Nicol Centre, Royal Sussex County Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom; and ††Departments of Biometrics, Virology, Clinical Operations, and HIV Clinical Research, Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001350DOI Listing
June 2017

Brief Report: Differential Effects of Tenofovir, Abacavir, Emtricitabine, and Darunavir on Telomerase Activity In Vitro.

J Acquir Immune Defic Syndr 2017 01;74(1):91-94

*Microbiology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; †HIV Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ‡Instituto de Investigaciones Biomédicas CSIC/UAM, IdiPAZ, Biomarkers and New Therapies and CIBER de Enfermedades Raras (CIBERER), Madrid, Spain; and §Universidad de Alcalá de Henares, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001154DOI Listing
January 2017

Probable sexual transmission of Zika virus from a vasectomised man.

Lancet Infect Dis 2016 10 19;16(10):1107. Epub 2016 Sep 19.

Department of Internal Medicine, Hospital Universitario La Paz-IdiPAZ, Madrid 28046, Spain; Department of Infectious Diseases Unit, Hospital Universitario La Paz-IdiPAZ, Madrid 28046, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(16)30320-6DOI Listing
October 2016

Convalescent Plasma for Ebola Virus Disease.

N Engl J Med 2016 06;374(25):2498-9

Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1602284DOI Listing
June 2016

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.

J Acquir Immune Defic Syndr 2016 May;72(1):58-64

*Department of Medicine, University of North Carolina, Chapel Hill, NC; †AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; ‡Department of Infectious Diseases, CHU Saint-Pierre University Hospital Brussels, Brussels, Belgium; §Elton John centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom; ‖Central Texas Clinical Research, Austin, TX; ¶Department of Internal Medicine, Mercer University School of Medicine, Macon, GA; #The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI; **Infectious Diseases Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ††Capital Center for Travel and Tropical Medicine, Washington, DC; ‡‡Internal Medicine Unit, Le Kremlin-Bicêtre Hospital, AP-HP Infectious Diseases Unit, Centre Hospitalier de Tourcoing Descartes University, Necker Hospital, AP-HP, Paris, France; §§Medicine, Maple Leaf Research, Department of Family and Community Medicine, University of Toronto, Toronto, CA; ‖‖Clinica delle Malattie Infettive e Tropicali, University of Modena and Reggio Emilia, Modena, Italy; ¶¶Department of Medicine and Center for AIDS Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ##Division of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; and ***Gilead Sciences, Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000940DOI Listing
May 2016

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

J Acquir Immune Defic Syndr 2016 Apr;71(5):530-7

*Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom; †Department of Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ‡Therapeutic Concepts, Houston, TX; §Department of Medicine, Indiana University School of Medicine, Indianapolis, IN; ‖King's College Hospital NHS Foundation Trust, London, United Kingdom; ¶Holdsworth House Medical Practice, Sydney, Australia; #HIV-NAT, Thai Red Cross AIDS Research Centre and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; **Gordon Crofoot Research, Houston, TX; ††Be Well Medical Center, Berkley, MI; ‡‡Department of Medicine, National Jewish Health, Denver, CO; §§Midway Research Center, Ft. Pierce, FL; ‖‖Department of Medicine, Khon Kaen University, Thailand; and ¶¶Gilead Sciences, Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000908DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804743PMC
April 2016

Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.

Virus Res 2016 Feb 29;213:224-229. Epub 2015 Dec 29.

Department of Microbiology, Instituto de Investigación Hospital 12 de Octubre (imas12), CAA, Avenida de Córdoba sn, 28041 Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01681702153018
Publisher Site
http://dx.doi.org/10.1016/j.virusres.2015.12.019DOI Listing
February 2016

Clinical Management of Ebola Virus Disease in the United States and Europe.

N Engl J Med 2016 Feb;374(7):636-46

From the Centers for Disease Control and Prevention (T.M.U., J.G.) and the Division of Infectious Diseases, Emory University School of Medicine (A.K.M.) - both in Atlanta; the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (R.T.D.); Texas Health Presbyterian Hospital Dallas, Dallas (A.M.L.); the Department of Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main (T.W.), the First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg (S.S.), and Leipzig Treatment Center for Highly Contagious Diseases, Klinikum St. Georg, Leipzig (T.G.) - all in Germany; the Division of Infectious Diseases and Laboratory of Virology, Geneva University Hospitals, Geneva (P.V.); the Department of Infection, Royal Free London NHS Foundation Trust, London (M.J.); the Internal Medicine Department, Infectious Diseases Unit Madrid, Hospital La Paz-Carlos III IdiPAZ, Madrid (J.R.A.); New York University School of Medicine-Bellevue Hospital Center, New York (L.E.); University of Nebraska Medical Center, Omaha (A.L.H.); the Departments of Infectious Diseases and Acute Medicine, Oslo University Hospital, Oslo (A.B.B.); Lazzaro Spallanzani National Institute for Infectious Diseases, Rome (G.I.); the Infectious and Tropical Diseases Department, Bégin Military Hospital, Saint-Mandé, France (C.R.); and the Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands (A.I.M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504874DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972324PMC
February 2016

Switching from tenofovir containing regimens to boosted protease inhibitor monotherapy: Impact on renal function.

Enferm Infecc Microbiol Clin 2016 Jan 27;34(1):29-32. Epub 2015 Feb 27.

HIV Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eimc.2015.01.013DOI Listing
January 2016

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.

AIDS 2016 Jan;30(2):251-9

aUniversity Medical Centre, Hamburg-Eppendorf, Infectious Diseases Unit, Hamburg, Germany bNational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy cGilead Sciences, Inc., Foster City, California, USA dHospital Universitario La Paz, IdiPAZ, Madrid, Spain eUniversity of North Carolina, Chapel Hill, North Carolina, USA fMedical University of Vienna, Vienna, Austria gUniversity of Toronto, Toronto, Ontario, Canada hHoldsworth House Medical Practice, Sydney, Australia iNew York Hospital Queens, Flushing, New York, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2016/01140/Rilpiviri
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000911DOI Listing
January 2016

Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.

AIDS 2016 Jan;30(1):75-82

aDepartment of DermatologybDepartment of Internal Medicine, Hospital Universitario La Paz-IdiPazcDepartment of ColoproctologydDepartment of Pathology, Hospital Universitario La PazeDepartment of Infectious Diseases, Hospital Universitario Ramon y Cajal, IRYCISfFundación SEIMC-GESIDAgBiostatistics Unit, Hospital Universitario La Paz-IdiPaz, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000886DOI Listing
January 2016

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues.

AIDS 2015 Sep;29(14):1811-20

aNational Institute for Infectious Diseases, L. Spallanzani IRCCS, Rome, Italy bBrighton and Sussex University Hospitals, Brighton, UK cKarolinska University, Sjukhuset, Sweden dHospital Universitario La Paz, IdiPAZ, Madrid, Spain eMedical Research Council, HIV Clinical Trials Unit, London, UK fDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland gCopenhagen University Hospital, Copenhagen, Denmark hWarsaw Medical University, Infectious Diseases, Warsaw, Poland iUniversity Hospital Germans Trias I Pujol, irsiCaixa, Badalona, Spain jInfectious Diseases, Ospedale Papa Giovanni XXIII, Bergamo, Italy kDepartment of Infectious and Tropical Diseases, Hôpital Saint-Antoine, AP-HP, and INSERM UMR S 1136, Paris, France lUniversity of Liverpool, Liverpool, UK mJanssen, EMEA, Neuss, Germany.

View Article

Download full-text PDF

Source
http://www.natap.org/2015/HIV/Week_48_efficacy_and_central_n
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000778DOI Listing
September 2015

Second-line antiretroviral therapy and the human factor.

Lancet HIV 2015 Feb 20;2(2):e34-5. Epub 2015 Jan 20.

HIV Unit, Hospital La Paz, IdiPAZ, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(15)00003-XDOI Listing
February 2015

A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy.

J Acquir Immune Defic Syndr 2014 Dec;67(4):419-23

*HIV Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; †Microbiology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ‡Psychiatry Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; and §Clinical Pharmacology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain (Dr Lakatos is now with Department of Infectious Diseases, Saint Laszlo Teaching Hospital of Semmelweis University, Budapest, Hungary).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000337DOI Listing
December 2014

Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study.

J Neurovirol 2014 Aug 24;20(4):362-70. Epub 2014 Apr 24.

HIV Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046, Madrid, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13365-014-0251-9DOI Listing
August 2014

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

N Engl J Med 2014 Jul;371(3):234-47

From the Medical Research Council Clinical Trials Unit at University College London, London (N.I.P., A.H., J.B., J.T., A.S.W.); Yong Loo Lin School of Medicine, National University of Singapore, Singapore (N.I.P.); Joint Clinical Research Centre (JCRC) (C.K., D.T., P.M.), Infectious Diseases Institute (A.K., I.M., P.J.E.), and St. Francis of Nsambya Hospital (R.M.), Kampala, JCRC, Mbarara (A.L.), JCRC, Fort Portal (M.K.), JCRC, Mbale (M.A.), JCRC, Gulu (G.A.), JCRC, Kabale (H.A.), and JCRC, Kakira (D.A.) - all in Uganda; University of Zimbabwe Clinical Research Centre, Harare (A.R., E.C., J.H.); Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre (J.J.O.), Dignitas International, Zomba (J.J.O.), and Mzuzu Central Hospital, Mzuzu (R.N.) - all in Malawi; Moi University School of Medicine, Eldoret, Kenya (A.S.); University Teaching Hospital, Lusaka, Zambia (A.M.); and Hospital La Paz, Madrid (J.R.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311274DOI Listing
July 2014

FLAMINGO: how much rosier can antiretroviral therapy get?

Lancet 2014 Jun 1;383(9936):2191-3. Epub 2014 Apr 1.

HIV Unit, Hospital La Paz, IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(14)60447-5DOI Listing
June 2014

Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.

AIDS 2014 Apr;28(7):989-97

aCommunity Research Initiative of New England, Boston, Massachusetts bUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA cHospital La Paz, Madrid, Spain dHIV Program Hennepin County Medical Center, Minneapolis, Minnesota, USA eUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany fHoldsworth House Medical Practice, Darlinghurst, New South Wales, Australia gDepartment of Infectious Disease, Kaiser Los Angeles Medical Center, Los Angeles, California, USA hNorth Manchester General Hospital, Manchester, UK iGilead Sciences, Foster City, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000169DOI Listing
April 2014

Long-term control of HIV replication with dolutegravir and pegylated interferon alpha-2a in an HIV-infected patient with sixtuple-class resistance.

AIDS 2014 Mar;28(6):932-4

aHIV Unit, Internal Medicine Service bNational Hemophilia Center, Sheba Medical Center, Israel cMicrobiology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2014/03270/Long_term
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000173DOI Listing
March 2014

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study.

J Acquir Immune Defic Syndr 2014 Jan;65(1):82-6

*HIV Unit, Service of Internal Medicine, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain; †Service of Infectious Diseases, Hospital Clínic/IDIBAPS, University of Barcelona, Barcelona, Spain; ‡Service of Infectious Diseases, Hospital Ramón y Cajal, Madrid, Spain; §HIV Clinical Unit, Internal Medicine Department and Fundació de la Lluita contra la SIDA, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain; ‖Unit of Infectious Diseases, Hospital Donostia, Donostia-San Sebastián, Spain; ¶Infectious Diseases and HIV Unit, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; #HIV Unit, Hospital 12 de Octubre and Universidad Europea de Madrid, Madrid, Spain; **Unit of Infectious Diseases, Hospital General Universitario de Valencia, Valencia, Spain; and ††Service of Internal Medicine, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a685dcDOI Listing
January 2014

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Clin Infect Dis 2013 Jul 26;57(1):112-21. Epub 2013 Mar 26.

Institute of Microbiology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cit196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669528PMC
July 2013

A benchmark for management of drug resistant HIV.

Lancet Infect Dis 2013 Jul 7;13(7):561-2. Epub 2013 May 7.

HIV/GUM Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, SW10 9NH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(13)70113-0DOI Listing
July 2013

Advances in antiretroviral therapy.

Curr Opin HIV AIDS 2013 Jul;8(4):341-9

Servicio de Medicina Interna, Unidad VIH Hospital La Paz, IdiPAZ. Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0b013e328361fabdDOI Listing
July 2013

Initial antiretroviral therapy: the dilemmas ahead.

Authors:
José R Arribas

Enferm Infecc Microbiol Clin 2013 Feb 29;31(2):68-70. Epub 2012 Aug 29.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0213005X120026
Publisher Site
http://dx.doi.org/10.1016/j.eimc.2012.07.011DOI Listing
February 2013

Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting.

AIDS Res Ther 2013 Jan 24;10(1). Epub 2013 Jan 24.

Consulta Medicina Interna 2, Hospital La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-6405-10-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610245PMC
January 2013

Protease inhibitor monotherapy: what is its role?

Curr HIV/AIDS Rep 2012 Jun;9(2):179-85

Servicio de Medicina Interna, Unidad VIH Hospital La Paz, IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11904-012-0112-1
Publisher Site
http://dx.doi.org/10.1007/s11904-012-0112-1DOI Listing
June 2012

Updating our understanding of pulmonary disease associated with HIV infection.

Arch Bronconeumol 2012 Apr 17;48(4):126-32. Epub 2012 Jan 17.

Unidad de VIH, Servicio de Medicina Interna, Hospital Universitario La Paz, IdiPAZ, Madrid, España.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03002896110039
Publisher Site
http://dx.doi.org/10.1016/j.arbres.2011.12.001DOI Listing
April 2012

Imported Plasmodium falciparum malaria in HIV-infected patients: a report of two cases.

Malar J 2012 Apr 27;11:136. Epub 2012 Apr 27.

Department of Microbiology and Parasitology, La Paz University Hospital-IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2875-11-136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358242PMC
April 2012

Protease inhibitor monotherapy and the CNS: peace of mind?

J Antimicrob Chemother 2011 Sep 13;66(9):1954-62. Epub 2011 Jun 13.

Servicio de Medicina Interna, Unidad VIH, Hospital La Paz, IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkr229DOI Listing
September 2011

Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy.

Antivir Ther 2011 ;16(1):59-65

HIV Unit, Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP1710DOI Listing
July 2011

Protease inhibitor monotherapy.

Curr Opin Infect Dis 2011 Feb;24(1):7-11

Servicio de Medicina Interna, Unidad VIH Hospital La Paz, IdiPAZ. Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QCO.0b013e3283422cdfDOI Listing
February 2011

Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine).

Authors:
Jose R Arribas

Curr Opin HIV AIDS 2009 Nov;4(6):507-12

Servicio de Medicina Interna, Unidad VIH Hospital La Paz, Universidad Autónoma de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0b013e328331b911DOI Listing
November 2009

Early versus deferred antiretroviral therapy for HIV.

N Engl J Med 2009 Aug;361(8):823; author reply 823-4

View Article

Download full-text PDF

Source
August 2009

[Role of the new molecules in antiretroviral therapy. Position of raltegravir].

Authors:
José R Arribas

Enferm Infecc Microbiol Clin 2008 Nov;26 Suppl 12:53-9

Consulta de Medicina Interna II (Unidad VIH), Hospital La Paz, Madrid, España.

View Article

Download full-text PDF

Source
November 2008

Antiretroviral rounds. Is that "one pill" treatment enough?

AIDS Clin Care 2008 Jul;20(7):53-4

View Article

Download full-text PDF

Source
July 2008

[Antiretroviral treatment in patient with advanced immunosuppression].

Med Clin (Barc) 2006 Feb;126(4):157-8; author reply 158-9

View Article

Download full-text PDF

Source
February 2006

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

N Engl J Med 2006 Jan;354(3):251-60

Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa051871DOI Listing
January 2006